Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:VTL

Vital Therapies (VTL) Stock Price, News & Analysis

Vital Therapies logo

About Vital Therapies Stock (NASDAQ:VTL)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$1.08
$1.18
50-Day Range
$0.83
$14.50
52-Week Range
$0.15
$9.75
Volume
1.10 million shs
Average Volume
21.62 million shs
Market Capitalization
$46.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.

Remove Ads
Receive VTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vital Therapies and its competitors with MarketBeat's FREE daily newsletter.

VTL Stock News Headlines

Partner with Elon Musk on Project Colossus… Before May 1st
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
Lighthouse Center for Vital Living celebrates new building
Vardhman Textiles Ltd.
See More Headlines

VTL Stock Analysis - Frequently Asked Questions

Vital Therapies, Inc. (NASDAQ:VTL) released its quarterly earnings results on Tuesday, August, 7th. The company reported ($0.30) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.03.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vital Therapies investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Endologix (ELGX), Anthera Pharmaceuticals (ANTH), Bristol-Myers Squibb (BMY), Novavax (NVAX) and Viking Therapeutics (VKTX).

Company Calendar

Last Earnings
8/07/2018
Today
4/01/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VTL
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-41,470,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.29 per share
Price / Book
3.76

Miscellaneous

Free Float
N/A
Market Cap
$46.18 million
Optionable
Not Optionable
Beta
3.51
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:VTL) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners